BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250929
DTEND;VALUE=DATE:20251001
DTSTAMP:20250919T181458Z
CREATED:20250919T181458Z
LAST-MODIFIED:20250919T181458Z
UID:63134-1759104000-1759276799@globalbiodefense.com
SUMMARY:Personal Protective Equipment for Influenza A (H5N1) in High-Risk Farm Settings: A Workshop
DESCRIPTION:The National Academies of Sciences\, Engineering\, and Medicine will host a two-day virtual public workshop\, Personal Protective Equipment for Influenza A (H5N1) in High-Risk Farm Settings\, on September 29–30\, 2025. This event will convene experts\, policymakers\, livestock industry leaders\, farm owners\, and frontline PPE users such as farmworkers and veterinarians to address urgent challenges posed by H5N1 transmission in agricultural environments. \nObjectives of the Workshop\nThe workshop aims to advance understanding and practical solutions around: \n\nCurrent State of Knowledge: Reviewing how H5N1 transmits to humans\, identifying high-risk activities\, and clarifying the role of PPE relative to engineering and administrative controls.\nBest Practices and Feasibility: Examining existing recommendations and identifying barriers to PPE use in farm settings\, with a focus on farmworker perspectives.\nRespiratory Protection: Exploring alternatives to NIOSH-approved respirators and their implications for respiratory protection programs.\nInnovative Technologies: Considering novel approaches to improve PPE fit\, usability\, and effectiveness\, including evaluation needs for emerging technologies.\nTraining and Communication: Enhancing health communication and education strategies to ensure workers understand the importance of PPE in preventing H5N1 transmission.\nResearch Gaps: Highlighting critical areas for future research to better protect workers and limit zoonotic spread. \n\nTarget Audience\nThis workshop is designed for: \n\nPublic health professionals and epidemiologists focused on infectious disease prevention.\nOccupational health and safety specialists.\nAgricultural stakeholders\, including farm owners and livestock industry leaders.\nPolicy advisors and decision-makers involved in global health security.\nFarmworkers\, veterinarians\, and PPE users operating in high-risk farm environments.\n\nWhy This Workshop Matters\nAs avian influenza A (H5N1) continues to present significant risks at the human-animal interface\, ensuring the protection of farmworkers is both a public health and occupational safety priority. PPE remains a critical component of disease prevention\, but implementation challenges—ranging from usability to accessibility—require collective attention. By creating a space for scientific exchange\, the workshop will help shape evidence-based strategies to strengthen preparedness and response. \nFor more information and registration details\, visit the National Academies event page.
URL:https://globalbiodefense.com/event/personal-protective-equipment-for-influenza-a-h5n1-in-high-risk-farm-settings-a-workshop/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250929T130000
DTEND;TZID=America/New_York:20250929T150000
DTSTAMP:20250925T173943Z
CREATED:20250925T173943Z
LAST-MODIFIED:20250925T173943Z
UID:63198-1759150800-1759158000@globalbiodefense.com
SUMMARY:Meeting of the Novel and Exceptional Technology and Research Advisory Committee (NExTRAC)
DESCRIPTION:The National Institutes of Health (NIH) will host the next public meeting of the Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) on September 29\, 2025\, from 1:00 PM to 3:00 PM (ET). This virtual meeting will bring together leaders in biomedical research\, clinical science\, and public health to deliberate on how best to engage the public as partners in clinical research. \nPurpose and Objectives\nThe upcoming meeting will focus on the Draft Report of the Engaging the Public as Partners in Clinical Research (ENGAGE) Working Group. Established by NIH in 2023\, the ENGAGE Working Group was charged with developing a framework to incorporate patient and community voices into NIH-funded clinical research. Its goals include: \n\nCreating a unified vision for public engagement in clinical research.\nDeveloping a practical framework with objectives and action steps across the research lifecycle.\nOffering recommendations to NIH on how to standardize meaningful\, equitable\, and sustainable engagement in clinical research.\n\nThis work responds directly to the NIH Director’s priority of rebuilding trust in clinical research and ensuring that studies are relevant\, feasible\, and impactful for the communities they are designed to serve. \nMeeting Highlights and Speakers\nThe agenda will include: \n\nWelcome and Recognition of NExTRAC Accomplishments\nLyric Jorgenson\, PhD\, Associate Director for Science Policy\, NIH\nCinnamon Bloss\, PhD\, University of California\, San Diego\nPresentation of the Draft ENGAGE Report\nSuzanne Bakken\, RN\, PhD\, Columbia University\nChristin Veasley\, Chronic Pain Research Alliance\nDeliberation on the Draft Report with NExTRAC members\, followed by closing reflections from Dr. Bloss.\n\n Why This Meeting Matters\nThe draft report underscores that clinical research engagement improves recruitment and retention\, increases study relevance\, builds public trust\, and strengthens dissemination of results. At the same time\, it acknowledges persistent challenges—such as financial constraints\, lack of training\, and limited organizational support—that can hinder meaningful engagement. \nTo address these\, the ENGAGE Working Group has proposed: \n\nCentering communities in research priorities.\nBuilding partnerships through trusted voices.\nDeveloping sustainable infrastructure and training.\nEnsuring fair compensation and recognition for community partners.\n\n Who Should Attend\nThis meeting will be of particular interest to: \n\nPublic health professionals and epidemiologists.\nGlobal health security experts.\nClinical and translational researchers.\nPatient advocacy leaders and community-based health organizations.\nPolicy professionals interested in research governance and public trust in science.\n\nBy attending\, participants will gain insights into the NIH’s evolving framework for research engagement and the policy directions that may shape future NIH-funded studies. \nFor more information about the NExTRAC meeting\, including registration details and access to meeting materials\, visit the NIH Office of Science Policy event page.
URL:https://globalbiodefense.com/event/meeting-of-the-novel-and-exceptional-technology-and-research-advisory-committee-nextrac/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250930T140000
DTEND;TZID=America/New_York:20250930T170000
DTSTAMP:20250925T170137Z
CREATED:20250925T170053Z
LAST-MODIFIED:20250925T170137Z
UID:63188-1759240800-1759251600@globalbiodefense.com
SUMMARY:Strengthening and Modernizing Biosafety Oversight: Region 1 Listening Session
DESCRIPTION:On September 30\, 2025\, the National Institutes of Health (NIH)\, in collaboration with the New England Biological Safety Association\, the Northeast Biological Safety Association\, the Mid-Atlantic Biological Safety Association\, and the Chesapeake Area Biological Safety Association\, will host the first in a series of public regional listening sessions aimed at strengthening and modernizing biosafety oversight. \nThis Region 1 session will take place virtually from 2:00–5:00 PM ET and will prioritize participation from stakeholders located in Maine\, New Hampshire\, Vermont\, Massachusetts\, Connecticut\, Rhode Island\, New York\, Pennsylvania\, New Jersey\, Delaware\, West Virginia\, Maryland\, and Washington\, D.C.. \nPurpose and Objectives\nThe initiative reflects NIH’s commitment to updating its biosafety framework in light of evolving research practices and new challenges in global health security. The listening session is designed to: \n\nGather Stakeholder Input: Solicit feedback on the scope of NIH’s biosafety policy\, including whether it should continue to focus on recombinant and synthetic nucleic acids or expand to encompass wild-type biological agents\, proteins (e.g.\, toxins\, prions)\, infectious microbes\, and other hazardous biological materials.\nAssess Oversight Needs: Identify categories of research that may warrant reduced local or NIH oversight\, such as non-biomedical research under USDA or EPA purview\, FDA-regulated clinical research\, or low-risk projects involving RG1 agents or certain transgenic organisms.\nPromote Transparency and Engagement: Provide a platform for scientists\, biosafety professionals\, and other stakeholders to share their perspectives on creating a more modern\, risk-based biosafety oversight system.\n\n \nFormat and Participation\nThe session will be webcast live via NIH Videocast\, ensuring accessibility for participants across the region. Pre-registration is required\, and attendees are encouraged to indicate if they wish to provide oral comments. Requests to make comments must be submitted by September 29\, 2025. \nAll oral contributions\, as well as written feedback\, will be considered as NIH and its partners refine the direction of biosafety modernization. Importantly\, the session is free and open to the public\, reinforcing the initiative’s emphasis on inclusivity and diverse stakeholder engagement. \nWho Should Attend\nThis session is particularly relevant to: \n\nPublic health and global health security professionals\nBiosafety officers and laboratory managers\nAcademic and government researchers conducting life sciences or biomedical research\nRegulatory and compliance officials working with NIH\, USDA\, EPA\, or FDA frameworks\nEpidemiologists and infectious disease experts interested in policy intersections with research oversight\n\nLooking Ahead\nThe Region 1 event represents just the beginning of NIH’s nationwide effort. By engaging local and regional stakeholders\, NIH aims to shape a modern\, flexible biosafety oversight framework that balances scientific innovation with safety and public trust. \nFor more information\, including the draft agenda\, registration link\, and participation details\, please visit the NIH Office of Science Policy’s event webpage.
URL:https://globalbiodefense.com/event/nih-strengthening-and-modernizing-biosafety-oversight-region-1-listening-session/
CATEGORIES:Government Hosted
LOCATION:
END:VEVENT
END:VCALENDAR